{"nctId":"NCT00367432","briefTitle":"A Long Term Follow up Administration Study of L059 (Levetiracetam) in Epilepsy Patients With Partial Onset Seizures","startDateStruct":{"date":"2006-07"},"conditions":["Epilepsies","Partial"],"count":398,"armGroups":[{"label":"Levetiracetam","type":"EXPERIMENTAL","interventionNames":["Drug: Levetiracetam"]}],"interventions":[{"name":"Levetiracetam","otherNames":["Keppra"]}],"eligibilityModule":{"eligibilityCriteria":"Inclusion Criteria:\n\n* Patients who participated in study N01221 \\[NCT00280696\\] and completed the evaluation period and transition period or patients who participated in study N01020 \\[NCT00160615\\]\n\nExclusion Criteria:\n\n* Female patients during pregnancy, delivery and lactation, or suspected of pregnancy","healthyVolunteers":false,"sex":"ALL","minimumAge":"16 Years","maximumAge":"65 Years","stdAges":["CHILD","ADULT","OLDER_ADULT"]},"locations":{"multicenter":true},"periods":[],"outcomeMeasures":[{"type":"PRIMARY","title":"Occurrence of Treatment-emergent Adverse Events During the Study Period (Until the Time of Approval Granted)","description":"An Adverse Event (AE) is any untoward medical occurrence in a clinical investigation subject administered a pharmaceutical product which does not necessarily have a causal relationship with the pharmaceutical product.\n\nOccurrence of treatment-emergent AEs is reported by the number of subjects with at least one treatment-emergent AE.","paramType":"NUMBER","dispersionType":null,"classes":[{"categories":[{"measurements":[{"groupId":"OG000","value":"381","spread":null}]}]}]},{"type":"SECONDARY","title":"Change From Baseline in N01221 [NCT00280696] in Partial (Type 1) Seizure Frequency Per Week During the First 16-week Period in This Study","description":"The change in partial (type 1) seizure frequency from Baseline is given as a percent reduction computed as:\n\n\\[ Weekly partial seizure frequency (Baseline)- Weekly partial seizure frequency (Evaluation Period)\\]/ \\[Weekly partial seizure frequency (Baseline)\\] x 100.\n\nPositive values in percent reduction means that the value has decreased from Baseline during the first 16-week Period.\n\nPartial (Type I) seizures can be classified into one of the following three groups: Simple partial seizures, Complex partial seizures, Partial seizures evolving to secondarily generalized seizures.","paramType":"MEDIAN","dispersionType":"Inter-Quartile Range","classes":[{"categories":[{"measurements":[{"groupId":"OG000","value":"22.00","spread":"53.04"}]}]}]},{"type":"SECONDARY","title":"Seizure Frequency Per Week in Partial Seizures During the First 16-week Period in This Study","description":"Partial (Type I) seizures can be classified into one of the following three groups: Simple partial seizures, Complex partial seizures, Partial seizures evolving to secondarily generalized seizures.","paramType":"MEDIAN","dispersionType":"Inter-Quartile Range","classes":[{"categories":[{"measurements":[{"groupId":"OG000","value":"2.13","spread":"7.32"}]}]}]},{"type":"SECONDARY","title":"Response Status (Patients With a Percent Reduction in Partial Seizure Frequency of at Least 50% During the First 16-week Period in This Study From Baseline in N01221)","description":"The percent reduction from Baseline was computed as:\n\n\\[ Weekly seizure frequency (Baseline)- Weekly seizure frequency (Evaluation Period)\\]/ \\[Weekly seizure frequency (Baseline)\\] x 100.\n\nResponders are those patients with a percent reduction in partial seizure frequency of at least 50% from Baseline to first Evaluation Period in partial seizure frequency per week.\n\nPartial (Type I) seizures can be classified into one of the following three groups: Simple partial seizures, Complex partial seizures, Partial seizures evolving to secondarily generalized seizures.","paramType":"NUMBER","dispersionType":null,"classes":[{"categories":[{"measurements":[{"groupId":"OG000","value":"74","spread":null}]}]},{"categories":[{"measurements":[{"groupId":"OG000","value":"239","spread":null}]}]}]},{"type":"SECONDARY","title":"Change From Baseline in N01221 [NCT00280696] in Simple Partial Seizure Frequency Per Week During the First 16-week Period in This Study","description":"Change in simple partial seizure frequency is given as a percent reduction computed as:\n\n\\[ Weekly simple partial seizure frequency (Baseline)- Weekly simple partial seizure frequency (Evaluation Period)\\]/ \\[Weekly simple partial seizure frequency (Baseline)\\] x 100.\n\nPositive values in percent reduction means that the value has decreased from Baseline during the first 16-week Period.\n\nPartial (Type I) seizures can be classified into one of the following three groups: Simple partial seizures, Complex partial seizures, Partial seizures evolving to secondarily generalized seizures.","paramType":"MEDIAN","dispersionType":"Inter-Quartile Range","classes":[{"categories":[{"measurements":[{"groupId":"OG000","value":"39.84","spread":"139.32"}]}]}]},{"type":"SECONDARY","title":"Change From Baseline in N01221 [NCT00280696] in Complex Partial Seizure Frequency Per Week During the First 16-week Period in This Study","description":"Change in complex partial seizure frequency is given as a percent reduction computed as:\n\n\\[ Weekly complex partial seizure frequency (Baseline)- Weekly complex partial seizure frequency (Evaluation Period)\\]/ \\[Weekly complex partial seizure frequency (Baseline)\\] x 100.\n\nPositive values in percent reduction means that the value has decreased from Baseline during the first 16-week Period.\n\nPartial (Type I) seizures can be classified into one of the following three groups: Simple partial seizures, Complex partial seizures, Partial seizures evolving to secondarily generalized seizures.","paramType":"MEDIAN","dispersionType":"Inter-Quartile Range","classes":[{"categories":[{"measurements":[{"groupId":"OG000","value":"20.59","spread":"85.94"}]}]}]},{"type":"SECONDARY","title":"Change From Baseline in N01221 [NCT00280696] in Secondary Generalized Seizure Frequency Per Week During the First 16-week Period in This Study","description":"Change in secondary generalized seizure frequency is given as a percent reduction computed as:\n\n\\[ Weekly sec. generalized seizure frequency (Baseline)- Weekly sec. generalized seizure frequency (Evaluation Period)\\]/ \\[Weekly sec. generalized seizure frequency (Baseline)\\] x 100.\n\nPositive values in reduction means the value decreased from Baseline during the first 16-week Period.\n\nSecondary generalized seizures belong to one of the 3 groups:\n\n* Simple partial sz evolving to gen sz\n* Complex partial sz evolving to gen sz\n* Simple partial sz evolving to Complex partial sz evolving to gen sz","paramType":"MEDIAN","dispersionType":"Inter-Quartile Range","classes":[{"categories":[{"measurements":[{"groupId":"OG000","value":"76.56","spread":"249.71"}]}]}]},{"type":"SECONDARY","title":"Change From Baseline in N01221 [NCT00280696] in Simple and Complex Partial Seizure Frequency Per Week During the First 16-week Period in This Study","description":"Change in simple and complex partial seizure frequency is given as a percent reduction computed as (simple and complex partial seizure frequency := A):\n\n\\[ Weekly A (Baseline)- Weekly A (Evaluation Period)\\]/ \\[Weekly A (Baseline)\\] x 100.\n\nPositive values in percent reduction means that the value has decreased from Baseline during the first 16-week Period.\n\nPartial (Type I) seizures can be classified into one of the following three groups: Simple partial seizures, Complex partial seizures, Partial seizures evolving to secondarily generalized seizures.","paramType":"MEDIAN","dispersionType":"Inter-Quartile Range","classes":[{"categories":[{"measurements":[{"groupId":"OG000","value":"20.71","spread":"63.01"}]}]}]},{"type":"SECONDARY","title":"Change From Baseline in N01221 [NCT00280696] in Other Types of Seizure Frequency Per Week During the First 16-week Period in This Study","description":"Change in other types of seizure frequency is given as a percent reduction computed as (other types of seizure frequency:= B):\n\n\\[ Weekly B (Baseline)- Weekly B (Evaluation Period)\\]/ \\[Weekly B (Baseline)\\] x 100.\n\nPositive values in percent reduction means that the value has decreased from Baseline during the first 16-week Period.\n\nOther types of Seizures are all seizures except Partial Seizures (Type 1).","paramType":"MEDIAN","dispersionType":"Inter-Quartile Range","classes":[{"categories":[{"measurements":[{"groupId":"OG000","value":"66.47","spread":"71.28"}]}]}]}],"adverseEventsModule":{"adverseEventsSummary":{"seriousAny":{"events":64,"n":398},"commonTop":["Nasopharyngitis","Somnolence","Contusion","Headache","Diarrhoea"]}}}